Micromet's P2P Acquisition

Micromet raised a round of funding on January 30, 2012. Investors include Amgen.

Micromet is focused on biological products for the treatment and control of cancer, inflammatory and autoimmune diseases. Using its antibody technology platforms, Micromet strives to create novel drug…

Articles about Micromet's P2P Acquisition: